Cargando…

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas

AIMS/INTRODUCTION: Type 2 diabetes mellitus is correlated with systemic atherosclerosis. Statin therapies have been proved to reduce low‐density lipoprotein cholesterol (LDL‐C) level, protecting type 2 diabetes mellitus patients from cardiovascular events. Recently, more interest has been focused on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xieda, Wu, Liting, Chen, Yan, Xiao, Huangmeng, Huang, Xiaoyu, Li, Yanbing, Xiao, Haipeng, Cao, Xiaopei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264389/ https://www.ncbi.nlm.nih.gov/pubmed/33289308 http://dx.doi.org/10.1111/jdi.13472

Ejemplares similares

Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study
por: Huang, Xiaoyu, et al.
Publicado: (2021)

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease
por: Shibasaki, Manabu, et al.
Publicado: (2015)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Controlling the thickness of the atherosclerotic plaque by statin medication
por: Formanowicz, Dorota, et al.
Publicado: (2020)

Early postpartum abnormal glucose metabolism subtype differs according to mid-trimester lipid profile in women with gestational diabetes mellitus
por: Lai, Fenghua, et al.
Publicado: (2021)

Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
por: Sezer, Ebru Demirel, et al.
Publicado: (2011)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
por: GUO, SUXIA, et al.
Publicado: (2012)

Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats
por: Koladiya, Rajeshkumar U, et al.
Publicado: (2008)

Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages
por: Sun, Yujiao, et al.
Publicado: (2020)

Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatin
por: SHA, TING, et al.
Publicado: (2016)

The Forty-Eight-Hour Week
Publicado: (1919)

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice
por: Li, Gang, et al.
Publicado: (2014)

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
por: Lee, Hae-Young, et al.
Publicado: (2014)

Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
por: Mita, Tomoya, et al.
Publicado: (2013)

Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease
por: Kobayashi, Junji
Publicado: (2022)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Changes in atherosclerotic plaque composition assessed by MRI in the superficial femoral artery with two years of lipid lowering therapy
por: West, Amy M, et al.
Publicado: (2011)

(99m)Tc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE(−/−) mice
por: Tan, Hui, et al.
Publicado: (2017)

A Forty-Eight Hours' Week
Publicado: (1920)

The Probationers' Forty-Eight-Hour Week
Publicado: (1920)

A Forty-Eight Hour Week
Publicado: (1919)

Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy
por: Peng, Shi, et al.
Publicado: (2018)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
por: Tokgözoglu, Lale, et al.
Publicado: (2020)

Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation
por: Komatsu, Tomohiro, et al.
Publicado: (2022)

Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin
por: Ekstrand, Matias, et al.
Publicado: (2015)

Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
por: Kawai, Yasuyuki, et al.
Publicado: (2011)

Mini-Review on the Efficacy and Safety of Pitavastatin: “The Novel Seventh Statin Gaining Momentum”
por: Ramadan, Azza, et al.
Publicado: (2022)

Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial
por: Park, Jun-Bean, et al.
Publicado: (2017)

Statin Treatment, Carotid Atherosclerotic Plaque Macrophage Infiltration and Circulating Inflammatory Markers
por: Koutouzis, Michael, et al.
Publicado: (2008)

Stabilization of symptomatic carotid atherosclerotic plaques by statins: a clinico-pathological analysis
por: Konishi, Takao, et al.
Publicado: (2018)

The Complementary Effects of Atorvastatin and Exercise Treatment on the Composition and Stability of the Atherosclerotic Plaques in ApoE Knockout Mice
por: Moustardas, Petros, et al.
Publicado: (2014)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits
por: van Hoof, Raf H. M., et al.
Publicado: (2017)

Forty-year-old diabetic lady with tightness in lower limbs
por: Khade, Snehaldatta S., et al.
Publicado: (2012)

Effects of Pitavastatin, Atorvastatin, and Rosuvastatin on the Risk of New-Onset Diabetes Mellitus: A Single-Center Cohort Study
por: Liu, Wei-Ting, et al.
Publicado: (2020)

CAVI-Lowering Effect of Pitavastatin May Be Involved in the Prevention of Cardiovascular Disease: Subgroup Analysis of the TOHO-LIP
por: Saiki, Atsuhito, et al.
Publicado: (2021)

Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
por: West, Amy M, et al.
Publicado: (2009)

Interventional hepatic apoC-III knockdown improves atherosclerotic plaque stability and remodeling by triglyceride lowering
por: Ramms, Bastian, et al.
Publicado: (2022)

Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
por: Edsfeldt, Andreas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m2gau8htd96hk1esjfbmf8q3ut